FDA Recalls Commonly Prescribed Thyroid Medication
The withdrawal involves 12 presentations and lots. This fact causes concern among patients who depend on these medications.
The Food and Drug Administration (FDA) announced a class II recall for levothyroxine sodium tablets, essential drugs in the treatment of hypothyroidism and to reduce the size of the thyroid gland when it is enlarged. This recall is due to the fact that the Major Pharmaceuticals and Cardinal Health products had lower potency than declared, affecting their effectiveness.
The retreat involves 12 presentations and lots, distributed nationwide. This fact causes concern among patients who depend on these medications. The FDA has not specified the exact number of recalled tablets.
The FDA defines recalls as actions necessary to remove products that pose a health risk from the market. In this case, it is considered that the tablets could cause temporary or medically reversible adverse effects.
For its part, Major Pharmaceuticals stated in an institutional communication that “it is not likely that the consumption of these batches will cause adverse health effects,” but reiterated the importance of returning the medication and consulting the doctor if symptoms appear, reported the Infobae portal.
Affected lots
The lots identified, from both Major Pharmaceuticals and Cardinal Health, include:
The FDA recommends patients, doctors and pharmacies review lot numbers and expiration dates to identify if they have any of the affected products.
Patients using the affected tablets should consult with their physicians to evaluate treatment alternatives.
What is levothyroxine sodium used for?
Mayo Clinic and the American Thyroid Association point out that levothyroxine sodium should be prescribed and adjusted by a health professional, since excess or deficiency of the hormone can cause health complications.
This medication, which is a synthetic form of thyroid T4, is essential in the treatment of several conditions involving the hormone.
This news has been tken from authentic news syndicates and agencies and only the wordings has been changed keeping the menaing intact. We have not done personal research yet and do not guarantee the complete genuinity and request you to verify from other sources too.

